Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jeffrey Goldberg, MD, received his medical degree from The University of Medicine and Dentistry of New Jersey, New Jersey Medical School in Newark, N.J. in 1983. He completed a residency in obstetrics and gynecology at Emory University in Atlanta, Ga., and a fellowship in reproductive endocrinology and infertility at The Ohio State University in Columbus, Ohio, where he remained on faculty until joining Cleveland Clinic in 1991. Currently, he Head of the Section of Reproductive Endocrinology and Infertility at Cleveland Clinic and holds the rank of professor at Cleveland Clinic Lerner College of Medicine. He is also the director of the Reproductive Endocrinology and Infertility fellowship program which he established in 2009.
He is board-certified in obstetrics and gynecology and subspecialty board-certified in reproductive endocrinology by the American Board of Obstetrics and Gynecology.
His clinical interests are advanced endoscopic surgery, microsurgical tubal anastomosis, in vitro fertilization and reproductive endocrinology. His research interests include endometriosis, reproductive surgery and in vitro fertilization.
Dr. Goldberg has published more than 200 scientific articles, abstracts and book chapters and three books on gynecologic endoscopic surgery. He has been an invited speaker at local, national and international meetings. He is a Fellow of the American College of Obstetrics and Gynecology and is a member of the American Society for Reproductive Medicine, The Society for Reproductive Endocrinologists, The Society for Reproductive Surgeons, The Society for Assisted Reproductive Technology, and The American Association of Gynecologic Laparoscopists. He is the past president of the Society for Reproductive Surgeons. He has served on the board of directors for both the American Society for Reproductive Medicine and The Society for Reproductive Surgeons. He is on the editorial board of several journals including Fertility and Sterility, as an ad hoc reviewer for many journals including The American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology, The Journal of Minimally Invasive Gynecology and Human Reproduction.
He was co-recipient of the Computerworld Smithsonian Research Innovation Award for robotic surgery, received the American College of Obstetricians and Gynecologists National Faculty Award for excellence in resident education as well as being selected as a Top Doc in Cleveland and Best Doctors in America since 2001. He is currently ranked in the top 1% of reproductive endocrinologists in the US by Castle-Connelly.
infertility, tubal ligation reversal (sterilization reversal), endometriosis, fibroids, reproductive surgery, operative laparoscopy, operative hysteroscopy, in vitro fertilization (IVF), polycystic ovary syndrome, amenorrhea, recurrent miscarriage, menstrual disorders
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/30/2016, Dr. Goldberg has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.